1. Home
  2. AZTR vs NCPL Comparison

AZTR vs NCPL Comparison

Compare AZTR & NCPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • NCPL
  • Stock Information
  • Founded
  • AZTR 2014
  • NCPL 1984
  • Country
  • AZTR United States
  • NCPL United States
  • Employees
  • AZTR N/A
  • NCPL N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • NCPL Investment Managers
  • Sector
  • AZTR Health Care
  • NCPL Finance
  • Exchange
  • AZTR Nasdaq
  • NCPL Nasdaq
  • Market Cap
  • AZTR 3.2M
  • NCPL 3.9M
  • IPO Year
  • AZTR 2023
  • NCPL N/A
  • Fundamental
  • Price
  • AZTR $0.25
  • NCPL $1.90
  • Analyst Decision
  • AZTR
  • NCPL
  • Analyst Count
  • AZTR 0
  • NCPL 0
  • Target Price
  • AZTR N/A
  • NCPL N/A
  • AVG Volume (30 Days)
  • AZTR 3.0M
  • NCPL 207.0K
  • Earning Date
  • AZTR 03-14-2025
  • NCPL 03-17-2025
  • Dividend Yield
  • AZTR N/A
  • NCPL N/A
  • EPS Growth
  • AZTR N/A
  • NCPL N/A
  • EPS
  • AZTR N/A
  • NCPL N/A
  • Revenue
  • AZTR $97,500.00
  • NCPL $1,702,723.00
  • Revenue This Year
  • AZTR N/A
  • NCPL N/A
  • Revenue Next Year
  • AZTR N/A
  • NCPL $101.16
  • P/E Ratio
  • AZTR N/A
  • NCPL N/A
  • Revenue Growth
  • AZTR N/A
  • NCPL N/A
  • 52 Week Low
  • AZTR $0.24
  • NCPL $1.41
  • 52 Week High
  • AZTR $68.40
  • NCPL $22.82
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 36.62
  • NCPL 48.30
  • Support Level
  • AZTR $0.24
  • NCPL $1.71
  • Resistance Level
  • AZTR $0.65
  • NCPL $1.95
  • Average True Range (ATR)
  • AZTR 0.06
  • NCPL 0.17
  • MACD
  • AZTR -0.02
  • NCPL -0.03
  • Stochastic Oscillator
  • AZTR 1.71
  • NCPL 28.36

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

About NCPL Netcapital Inc.

Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.

Share on Social Networks: